Departed
Timothy F. Murphy
Chief Financial Officer
ROCK ·
GIBRALTAR INDUSTRIES, INC.
Mr. Lovechio will succeed Timothy F. Murphy, who recently announced his plans to retire.
Executive movement radar
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 7751–7800 of 76387
Departed
Michael Kauffman
Director
ACET ·
Adicet Bio, Inc.
Michael Kauffman, M.D., Ph.D., a Class III member of the board of directors (the “Board”) of Adicet Bio, Inc. (the “Company”), notified the Company of his resignation from the Board and Nominating and Corporate Governance Committee (the “NCG Committee”), effective as of August 19, 2024.
Departed
David Willis
Director
EWCZ ·
European Wax Center, Inc.
On August 15, 2024, David Willis resigned from the board of directors (the “Board”) of European Wax Center, Inc. (the “Company”), effective August 15, 2024.
Departed
Stan Little
director
SRFM ·
SURF AIR MOBILITY INC.
On August 18, 2024, director Stan Little resigned from the Board of Directors of Surf Air Mobility Inc. (the “Company”), effective as of August 18, 2024.
Departed
Mark Austin
Vice President of Finance, Corporate Controller and Corporate Secretary
CATX ·
Perspective Therapeutics, Inc.
On August 16, 2024 (the “ Effective Date ”), Mark Austin, the Vice President of Finance, Corporate Controller and Corporate Secretary of Perspective Therapeutics, Inc. (the “ Company ”), ceased serving as an executive officer and as the Company’s “co-principal financial officer” and “principal accounting officer.”
Departed
YiYi Huang
Chief Financial Officer
SNTW ·
Summit Networks Inc.
On August 15, 2024, Ms. YiYi Huang resigned as CFO of Summit Networks Inc.
Departed
Howard Berman
Chief Executive Officer
COYA ·
Coya Therapeutics, Inc.
Dr. Howard Berman, who, on August 16, 2024, notified the Company that he would be resigning as Chief Executive Officer of the Company effective at the close of business on October 31, 2024.
Departed
Marschall S. Runge
Director
LLY ·
ELI LILLY & Co
On August 13, 2024, Dr. Marschall S. Runge notified the Board of Directors (the "Board") of Eli Lilly and Company (the "Company") of his decision to retire from the Board, effective as of August 31, 2024.
Departed
Jim Hinrichs
Director and Audit Committee Chair
OM ·
Outset Medical, Inc.
On August 15, 2024, Jim Hinrichs, a member of the Board of Directors (the “Board”) of Outset Medical, Inc. (the “Company”), notified the Company of his decision to resign from the Board and his role as Audit Committee Chair, effective immediately.
Departed
Jesus Rodriguez Calvo
Senior Vice President, North American Sales
FDP ·
FRESH DEL MONTE PRODUCE INC
Effective August 16, 2024, Jesus Rodriguez Calvo, Senior Vice President, North American Sales of Fresh Del Monte Produce Inc. (the “Company”), will retire from the Company.
Departed
Janice 'Jan' Williams
Chief Credit Officer
EGBN ·
EAGLE BANCORP INC
On August 16, 2024, Janice “Jan” Williams, Executive Vice President of Eagle Bancorp, Inc. (the “Company”) and the Chief Credit Officer of EagleBank (the “Bank”), a wholly owned subsidiary of the Company, notified the Company and the Bank of her intent to retire from the Bank effective June 30, 2025.
Departed
Ranson W. Webster
Director
HERITAGE COMMERCE CORP
Director Ranson W. Webster, announcing that Mr. Webster would retire and withdraw as a director of the Company effective as of October 1, 2024.
Departed
Darrel Hackett
Director
MAGN ·
Magnera Corp
Kathleen A. Dahlberg, Marie T. Gallagher, Darrel Hackett and J. Robert Hall will retire from the Glatfelter board upon the Closing.
Departed
Kathleen A. Dahlberg
Director
MAGN ·
Magnera Corp
Kathleen A. Dahlberg, Marie T. Gallagher, Darrel Hackett and J. Robert Hall will retire from the Glatfelter board upon the Closing.
Departed
Marie T. Gallagher
Director
MAGN ·
Magnera Corp
Kathleen A. Dahlberg, Marie T. Gallagher, Darrel Hackett and J. Robert Hall will retire from the Glatfelter board upon the Closing.
Departed
J. Robert Hall
Director
MAGN ·
Magnera Corp
Kathleen A. Dahlberg, Marie T. Gallagher, Darrel Hackett and J. Robert Hall will retire from the Glatfelter board upon the Closing.
Departed
Kathleen P. Bloch
Chief Financial Officer
CTSO ·
Cytosorbents Corp
the Company also announced the retirement of Ms. Kathleen P. Bloch, the Company’s then serving Chief Financial Officer, and her transition into a consulting role with the Company.
Departed
Alexander Ovtchinnikov
Senior Vice President, Chief Technology Officer
IPGP ·
IPG PHOTONICS CORP
On August 15, 2024, Alexander Ovtchinnikov, Ph.D., Senior Vice President, Chief Technology Officer of IPG Photonics Corporation (the “Company”), informed the Company of his intention to retire from employment with the Company effective September 15, 2024
Departed
Praveen P. Tipirneni
Director
Morphic Holding, Inc.
each of Gustav Christensen, Timothy A. Springer, Ph.D., Norbert Bischofberger, Ph.D., Martin Edwards, Susannah Gray, Nisha Nanda, Ph.D, Amir Nashat, Sc.D., Joseph P. Slattery, and Praveen P. Tipirneni, M.D. resigned from his or her respective position as a member of the Company’s board of directors and all committees thereof, effective as of the Effective Time
Departed
Martin Edwards
Director
Morphic Holding, Inc.
each of Gustav Christensen, Timothy A. Springer, Ph.D., Norbert Bischofberger, Ph.D., Martin Edwards, Susannah Gray, Nisha Nanda, Ph.D, Amir Nashat, Sc.D., Joseph P. Slattery, and Praveen P. Tipirneni, M.D. resigned from his or her respective position as a member of the Company’s board of directors and all committees thereof, effective as of the Effective Time
Departed
Gustav Christensen
Director
Morphic Holding, Inc.
each of Gustav Christensen, Timothy A. Springer, Ph.D., Norbert Bischofberger, Ph.D., Martin Edwards, Susannah Gray, Nisha Nanda, Ph.D, Amir Nashat, Sc.D., Joseph P. Slattery, and Praveen P. Tipirneni, M.D. resigned from his or her respective position as a member of the Company’s board of directors and all committees thereof, effective as of the Effective Time
Departed
Norbert Bischofberger
Director
Morphic Holding, Inc.
each of Gustav Christensen, Timothy A. Springer, Ph.D., Norbert Bischofberger, Ph.D., Martin Edwards, Susannah Gray, Nisha Nanda, Ph.D, Amir Nashat, Sc.D., Joseph P. Slattery, and Praveen P. Tipirneni, M.D. resigned from his or her respective position as a member of the Company’s board of directors and all committees thereof, effective as of the Effective Time
Departed
Timothy A. Springer
Director
Morphic Holding, Inc.
each of Gustav Christensen, Timothy A. Springer, Ph.D., Norbert Bischofberger, Ph.D., Martin Edwards, Susannah Gray, Nisha Nanda, Ph.D, Amir Nashat, Sc.D., Joseph P. Slattery, and Praveen P. Tipirneni, M.D. resigned from his or her respective position as a member of the Company’s board of directors and all committees thereof, effective as of the Effective Time
Departed
Joseph P. Slattery
Director
Morphic Holding, Inc.
each of Gustav Christensen, Timothy A. Springer, Ph.D., Norbert Bischofberger, Ph.D., Martin Edwards, Susannah Gray, Nisha Nanda, Ph.D, Amir Nashat, Sc.D., Joseph P. Slattery, and Praveen P. Tipirneni, M.D. resigned from his or her respective position as a member of the Company’s board of directors and all committees thereof, effective as of the Effective Time
Departed
Nisha Nanda
Director
Morphic Holding, Inc.
each of Gustav Christensen, Timothy A. Springer, Ph.D., Norbert Bischofberger, Ph.D., Martin Edwards, Susannah Gray, Nisha Nanda, Ph.D, Amir Nashat, Sc.D., Joseph P. Slattery, and Praveen P. Tipirneni, M.D. resigned from his or her respective position as a member of the Company’s board of directors and all committees thereof, effective as of the Effective Time
Departed
Amir Nashat
Director
Morphic Holding, Inc.
each of Gustav Christensen, Timothy A. Springer, Ph.D., Norbert Bischofberger, Ph.D., Martin Edwards, Susannah Gray, Nisha Nanda, Ph.D, Amir Nashat, Sc.D., Joseph P. Slattery, and Praveen P. Tipirneni, M.D. resigned from his or her respective position as a member of the Company’s board of directors and all committees thereof, effective as of the Effective Time
Departed
Susannah Gray
Director
Morphic Holding, Inc.
each of Gustav Christensen, Timothy A. Springer, Ph.D., Norbert Bischofberger, Ph.D., Martin Edwards, Susannah Gray, Nisha Nanda, Ph.D, Amir Nashat, Sc.D., Joseph P. Slattery, and Praveen P. Tipirneni, M.D. resigned from his or her respective position as a member of the Company’s board of directors and all committees thereof, effective as of the Effective Time
Departed
James Vance
Director
STI ·
Solidion Technology Inc.
On August 12, 2024, James Vance notified the Board of Directors (the “Board”) of the Company of his resignation as a member of the Board, effective as of such date.
Departed
Cathy Jiang
Director
CTOR ·
CITIUS ONCOLOGY, INC.
each of Cathy Jiang and Brian Hartzband resigned as directors
Departed
Brian Hartzband
Director
CTOR ·
CITIUS ONCOLOGY, INC.
each of Cathy Jiang and Brian Hartzband resigned as directors
Departed
Xiaofeng Yuan
Chief Executive Officer
CTOR ·
CITIUS ONCOLOGY, INC.
Xiaofeng Yuan resigned as Chief Executive Officer and Chairman of the Board
Departed
Taylor Zhang
Chief Financial Officer
CTOR ·
CITIUS ONCOLOGY, INC.
Taylor Zhang resigned as Chief Financial Officer and a director
Departed
Nicolette Sloan
Executive Vice President and Head of Growth & Strategy
BMRC ·
Bank of Marin Bancorp
On July 19, 2024, Registrant’s wholly owned subsidiary, Bank of Marin (“Bank”) terminated the employment of Nicolette Sloan, Executive Vice President and Head of Growth & Strategy at the Bank, as part of a broader reduction in force.
Departed
Andrea Park
Interim Chief Financial Officer and Chief Accounting Officer
SER ·
Serina Therapeutics, Inc.
On August 12, 2024, the Company informed Andrea Park, the Company’s Interim Chief Financial Officer and Chief Accounting Officer, that her employment with the Company will end effective August 15, 2024.
Departed
Punit Dhillon
member of the Board
Arch Therapeutics, Inc.
On August 14, 2024, Punit Dhillon notified the board of directors (the “Board”) of Arch Therapeutics, Inc. (the “Company”) that he will resign as a member of the Board effective August 14, 2024.
Departed
Eren Bali
Director
UDMY ·
Udemy, Inc.
Eren Bali resigned from the Board of Directors (the "Board") of Udemy, Inc. (the "Company") and its committees
Departed
Jeffrey Margolis
Director
ALHC ·
Alignment Healthcare, Inc.
On August 13, 2024 and August 14, 2024, respectively, Jeffrey Margolis and Thomas Carella each notified the Board of Directors (the "Board") of Alignment Healthcare, Inc. (the "Company") of their decision to resign as a member of the Board, effective immediately.
Departed
Thomas Carella
Director
ALHC ·
Alignment Healthcare, Inc.
On August 13, 2024 and August 14, 2024, respectively, Jeffrey Margolis and Thomas Carella each notified the Board of Directors (the "Board") of Alignment Healthcare, Inc. (the "Company") of their decision to resign as a member of the Board, effective immediately.
Departed
David Barnes
Chief Financial Officer
TRMB ·
TRIMBLE INC.
David Barnes, the Company’s current Chief Financial Officer, has agreed to remain with the Company to lead its efforts in assisting Ernst & Young LLP (“EY”), the Company’s independent registered public accounting firm, as EY performs incremental audit procedures to complete its previously announced audit of the Company’s consolidated financial statements
Departed
Jill Frizzley
Director
KLDiscovery Inc.
each of Ian Fujiyama, Jill Frizzley, Neal P. Goldman, Kevin Griffin, Evan Morgan, Lawrence Prior III, Arjun Shah, Lauren Tanenbaum, Christopher J. Weiler and Richard Williams resigned from his or her respective position as a member of the Company’s board of directors, and any committee thereof, effective as of the Closing (which resignations were tendered in connection with the Transactions and not as a result of any disagreements between the Company and the resigning individuals on any matters related to the Company’s operations, policies, or practices); and
Departed
Ian Fujiyama
Director
KLDiscovery Inc.
each of Ian Fujiyama, Jill Frizzley, Neal P. Goldman, Kevin Griffin, Evan Morgan, Lawrence Prior III, Arjun Shah, Lauren Tanenbaum, Christopher J. Weiler and Richard Williams resigned from his or her respective position as a member of the Company’s board of directors, and any committee thereof, effective as of the Closing (which resignations were tendered in connection with the Transactions and not as a result of any disagreements between the Company and the resigning individuals on any matters related to the Company’s operations, policies, or practices); and
Departed
Lauren Tanenbaum
Director
KLDiscovery Inc.
each of Ian Fujiyama, Jill Frizzley, Neal P. Goldman, Kevin Griffin, Evan Morgan, Lawrence Prior III, Arjun Shah, Lauren Tanenbaum, Christopher J. Weiler and Richard Williams resigned from his or her respective position as a member of the Company’s board of directors, and any committee thereof, effective as of the Closing (which resignations were tendered in connection with the Transactions and not as a result of any disagreements between the Company and the resigning individuals on any matters related to the Company’s operations, policies, or practices); and
Departed
Christopher J. Weiler
Director
KLDiscovery Inc.
each of Ian Fujiyama, Jill Frizzley, Neal P. Goldman, Kevin Griffin, Evan Morgan, Lawrence Prior III, Arjun Shah, Lauren Tanenbaum, Christopher J. Weiler and Richard Williams resigned from his or her respective position as a member of the Company’s board of directors, and any committee thereof, effective as of the Closing (which resignations were tendered in connection with the Transactions and not as a result of any disagreements between the Company and the resigning individuals on any matters related to the Company’s operations, policies, or practices); and
Departed
Neal P. Goldman
Director
KLDiscovery Inc.
each of Ian Fujiyama, Jill Frizzley, Neal P. Goldman, Kevin Griffin, Evan Morgan, Lawrence Prior III, Arjun Shah, Lauren Tanenbaum, Christopher J. Weiler and Richard Williams resigned from his or her respective position as a member of the Company’s board of directors, and any committee thereof, effective as of the Closing (which resignations were tendered in connection with the Transactions and not as a result of any disagreements between the Company and the resigning individuals on any matters related to the Company’s operations, policies, or practices); and
Departed
Kevin Griffin
Director
KLDiscovery Inc.
each of Ian Fujiyama, Jill Frizzley, Neal P. Goldman, Kevin Griffin, Evan Morgan, Lawrence Prior III, Arjun Shah, Lauren Tanenbaum, Christopher J. Weiler and Richard Williams resigned from his or her respective position as a member of the Company’s board of directors, and any committee thereof, effective as of the Closing (which resignations were tendered in connection with the Transactions and not as a result of any disagreements between the Company and the resigning individuals on any matters related to the Company’s operations, policies, or practices); and
Departed
Evan Morgan
Director
KLDiscovery Inc.
each of Ian Fujiyama, Jill Frizzley, Neal P. Goldman, Kevin Griffin, Evan Morgan, Lawrence Prior III, Arjun Shah, Lauren Tanenbaum, Christopher J. Weiler and Richard Williams resigned from his or her respective position as a member of the Company’s board of directors, and any committee thereof, effective as of the Closing (which resignations were tendered in connection with the Transactions and not as a result of any disagreements between the Company and the resigning individuals on any matters related to the Company’s operations, policies, or practices); and
Departed
Richard Williams
Director
KLDiscovery Inc.
each of Ian Fujiyama, Jill Frizzley, Neal P. Goldman, Kevin Griffin, Evan Morgan, Lawrence Prior III, Arjun Shah, Lauren Tanenbaum, Christopher J. Weiler and Richard Williams resigned from his or her respective position as a member of the Company’s board of directors, and any committee thereof, effective as of the Closing (which resignations were tendered in connection with the Transactions and not as a result of any disagreements between the Company and the resigning individuals on any matters related to the Company’s operations, policies, or practices); and
Departed
Lawrence Prior III
Director
KLDiscovery Inc.
each of Ian Fujiyama, Jill Frizzley, Neal P. Goldman, Kevin Griffin, Evan Morgan, Lawrence Prior III, Arjun Shah, Lauren Tanenbaum, Christopher J. Weiler and Richard Williams resigned from his or her respective position as a member of the Company’s board of directors, and any committee thereof, effective as of the Closing (which resignations were tendered in connection with the Transactions and not as a result of any disagreements between the Company and the resigning individuals on any matters related to the Company’s operations, policies, or practices); and
Departed
Arjun Shah
Director
KLDiscovery Inc.
each of Ian Fujiyama, Jill Frizzley, Neal P. Goldman, Kevin Griffin, Evan Morgan, Lawrence Prior III, Arjun Shah, Lauren Tanenbaum, Christopher J. Weiler and Richard Williams resigned from his or her respective position as a member of the Company’s board of directors, and any committee thereof, effective as of the Closing (which resignations were tendered in connection with the Transactions and not as a result of any disagreements between the Company and the resigning individuals on any matters related to the Company’s operations, policies, or practices); and
Departed
Isidoro Quiroga Cortés
director
FTCI ·
FTC Solar, Inc.
On August 15, 2024, the Company issued a press release announcing that Isidoro Quiroga Cortés resigned from his position as a director of FTC Solar, Inc. (the “Company”), effective August 11, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.